School of Medicine
Showing 641-660 of 13,047 Results
-
Michael Baiocchi
Associate Professor of Epidemiology and Population Health and, by courtesy, of Statistics and of Medicine (Stanford Prevention Research Center)
BioProfessor Baiocchi is a PhD statistician in Stanford University's Epidemiology and Population Health Department. He thinks a lot about behavioral interventions and how to rigorously evaluate if and how they work. Methodologically, his work focuses on creating statistically rigorous methods for causal inference that are transparent and easy to critique. He designed -- and was the principle investigator for -- two large randomized studies of interventions to prevent sexual assault in the settlements of Nairobi, Kenya.
Professor Baiocchi is an interventional statistician (i.e., grounded in both the creation and evaluation of interventions). The unifying idea in his research is that he brings rigorous, quantitative approaches to bear upon messy, real-world questions to better people's lives. -
Simar Bajaj
MD Student, expected graduation Spring 2031
BioSimar Bajaj is a medical student and Knight-Hennessy Scholar at Stanford University School of Medicine with interests in internal medicine, health policy, and science journalism. He studied Global Health Science and Epidemiology at the University of Oxford as a Marshall Scholar and studied Chemistry and the History of Science at Harvard University, where he graduated summa cum laude.
His research focuses on stigmatized diseases like obesity, lung cancer, and substance use disorder with first-author work in The Lancet, New England Journal of Medicine, Nature Medicine, British Medical Journal, Annals of Internal Medicine, and Annals of Surgery.
Simar is also an an award-winning journalist and, until recently, worked as a health and wellness reporter at the New York Times (https://www.nytimes.com/by/simar-bajaj). His writing has also appeared in NPR, The Atlantic, The Economist, The Washington Post, National Geographic, and more. He is currently working on a book about stigmatized diseases. -
Vikram S Bajaj
Adjunct Professor, Rad/Molecular Imaging Program at Stanford
BioAdj. Professor, Stanford Radiology.
Managing Director, Foresite Capital Management
Co-Founder/CEO, Foresite Labs
Previous:
Chief Scientific Officer, GRAIL
Chief Scientific Officer and Co-Founder, Verily (Google Life Sciences) -
Sepideh Bajestan, MD, PhD
Clinical Professor, Psychiatry and Behavioral Sciences
Current Research and Scholarly InterestsNeuropsychiatry
Functional Neurological Symptom Disorders, Psychogenic Non-Epileptic Seizures
Group and Individual Psychotherapy
Impulse Control Disorders -
Julie Baker
Professor of Genetics
Current Research and Scholarly InterestsWe examine how cells communicate and function during fetal development. The work in my laboratory focuses on the establishment of specific cell fates using genomics to decipher interactions between chromatin and developmental signaling cascades, between genomes and rapidly evolving cell types, and between genomic copy number variation and gene expression. In recent years we have focused on the vastly understudied biology of the trophoblast lineage, particularly how this lineage evolved.
-
Justin Nathaniel Baker
Deborah E. Addicott - John A. Kriewall and Elizabeth A. Haehl Family Professor of Pediatrics
BioAs a Pediatric Oncologist, Palliative Care Physician, and Phase I and End– of– Life Care Clinical Investigator, I am intimately aware of the distress experienced by children with advanced cancer and the ethical and end– of– life/bereavement issues surrounding their disease progression. I currently serve as the Chief of the Division of Quality of Life and Pediatric Palliative Care here at Stanford, as well as the Director of the Quality of Life for All (QoLA) Program. Additionally, I serve as the Associate Chief Quality Officer for Patient Experience and Holistic Care. In my past career at St Jude, I served as the Director of our large Pediatric Hematology/Oncology Fellowship Program for more than a decade. My research interests include ethical considerations surrounding enrollment in Phase I clinical trials, AYA palliative oncology care, end– of– life decision making, grief and bereavement, integrating palliative care into the ongoing care of children with cancer as well as patient– reported outcomes and pain and symptom control in the context of pediatric oncology care. I have received significant extramural funding for my research, and I have participated in dozens of studies related to pediatric palliative care. I have authored ~300 academic works on a broad array of palliative care subjects. In sum, I am a recognized global expert and leader in the field of Pediatric Palliative Care.
-
Laurence Baker
Josephine Knotts Knowles Professor of Human Biology, Senior Fellow at the Stanford Institute for Economic Policy Research and Professor, by courtesy, of Economics
On Partial Leave from 2026-09-01 To 2026-10-31Current Research and Scholarly InterestsDr. Baker's research is in the area of health economics, and focuses on the effects of financial incentives, organizational structures, and government policies on the health care delivery system, health care costs, and health outcomes.
-
Matthew C. Baker, MD MS
Associate Professor of Medicine (Immunology and Rheumatology)
BioDr. Baker is an Associate Professor of Medicine and Associate Division Chief in the Division of Immunology and Rheumatology at Stanford University. He is an internationally recognized expert in IgG4-related disease and is the Co-Founder and Co-Director of the Stanford Multidisciplinary Sarcoidosis Program. Dr. Baker received his bachelor's degree from Pomona College, his medical degree from Harvard Medical School, and a master's degree in Epidemiology and Clinical Research from Stanford University. He completed his residency in Internal Medicine at Massachusetts General Hospital and his fellowship in Rheumatology at Stanford University.
Dr. Baker's research program spans clinical trials, epidemiology, and translational science with the goal of accelerating the development of innovative therapies for immune-mediated diseases. He has designed and led investigator-initiated and industry-sponsored clinical trials in IgG4-related disease, sarcoidosis, Sjögren's disease, and rheumatoid arthritis. His epidemiologic research focuses on defining disease mechanisms, identifying novel therapeutic targets, and repurposing existing medications, including for the treatment of osteoarthritis.
Dr. Baker is also the Co-Founder and Co-Director of the Stanford Immune Reset Program, an interdisciplinary initiative dedicated to advancing transformative therapies with curative potential for autoimmune diseases, including T-cell engagers and in vivo CAR T-cell therapies. -
Rachel Baker
Unit/Program Communicator 4, Surgery
BioAs the Director of Communications for Stanford Surgery, Rachel Baker tells the stories of her department's faculty, staff, and trainees.
With the help of an amazing team of content creators, she produces and curates original articles, photos, videos, graphics, and podcasts. She works with each division, center, program, and lab within her purview to define their audience and reach their goals while maintaining a consistent brand voice. She also offers both 1:1 and group education on a variety of topics including media training, using social media to advantage, and presentation refinement.
Rachel holds a Bachelor's degree in journalism with a focus on photography from Syracuse University's S.I. Newhouse School of Public Communications and is currently pursuing a Master's Degree in Strategic Communications from the University of Maryland.
